Cardioplegia Solution, Reperfusate 4:1 low potassium, 15 mEq K, packaged in 477.5 mL per bag, Rx ...

FDA Recall #D-0653-2023 — Class II — April 28, 2023

Recall #D-0653-2023 Date: April 28, 2023 Classification: Class II Status: Terminated

Product Description

Cardioplegia Solution, Reperfusate 4:1 low potassium, 15 mEq K, packaged in 477.5 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0008-1.

Reason for Recall

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Recalling Firm

Central Admixture Pharmacy Services, Inc. — Allentown, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

338 bags

Distribution

Nationwide in the USA.

Code Information

Lot # 37-893847, Exp 04/28/2023; 37-895646, Exp 05/05/2023; 37-897804, Exp 05/12/2023; 37-899236, Exp 05/19/2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated